|
Socio-demographic
|
66
| | |
|
Race and/or ethnicity
|
17
| |
[23, 25, 36,37,38, 40, 44, 45, 79,80,81,82,83,84,85,86,87]
|
|
Patients’ age
|
16
|
Young: ≤ 45 years old, Older: > 45 years old
|
[26, 33, 39, 43, 51, 87,88,89,90,91,92,93,94,95,96,97]
|
|
Gender
|
12
| |
[41, 56, 67, 72, 79, 92, 94, 97,98,99,100,101]
|
|
Obesity / weight related
|
7
| | |
|
- Body mass index / obesity
|
6
| |
[17, 49, 58, 59, 102, 103]
|
|
- Waist circumference
|
1
| |
[59]
|
|
- Weight change over time
|
1
| |
[104]
|
|
Lifestyle factors
|
6
| | |
|
- Level / patterns of physical activity
|
4
| |
[20, 32, 57, 105]
|
|
- Lifestyle patterns
|
3
|
Morningness-eveningness, sleep quality, Consumption of food, alcohol and cigarettes [106]
|
[20, 106, 107]
|
|
Dietary factors / patterns
|
6
|
e.g. intake of coffee, high fat dietary pattern score
|
[57, 108,109,110,111,112]
|
|
Education related
|
4
| | |
|
- Level of literacy
|
2
| |
[48, 107]
|
|
- Level of health literacy
|
1
| |
[18]
|
|
- Verbal intelligence
|
1
|
Groningen Intelligence Test [113]
|
[113]
|
|
Economic related factors
|
4
| | |
|
- Household income
|
2
| |
[48, 114]
|
|
- Socio-economic status of patients
|
1
| |
[115]
|
|
- Employment status
|
1
| |
[107]
|
|
Smoking
|
4
| | |
|
- Current smoking status
|
3
| |
[20, 34, 57]
|
|
- Smoking duration
|
1
| |
[107]
|
|
Alcohol consumption
|
1
| |
[57]
|
|
Citizenship (immigrant / non-immigrant)
|
1
| |
[116]
|
|
Living in Northern vs Southern latitudes
|
1
| |
[117]
|
|
Marital status
|
1
| |
[107]
|
|
Diabetes related
|
54
| | |
|
Hba1c related
|
14
| | |
|
- Hba1c level
|
7
| |
[74, 76, 103, 118,119,120,121]
|
|
- Patterns, trends and trajectories
|
6
| |
[11, 75, 122,123,124,125]
|
|
- Hba1c variability
|
2
| |
[125, 126]
|
|
Diabetes related complications
|
13
| | |
|
- Presence of albuminuria
|
4
| |
[26, 54, 68, 127]
|
|
- Presence of complications e.g. cardiometabolic, microvascular diseases
|
3
| |
[10, 50, 128]
|
|
- Presence of diabetic retinopathy
|
2
| |
[129, 130]
|
|
- Severity of albuminuria
|
1
| |
[54]
|
|
- Presence of diabetic nephropathy
|
1
| |
[130]
|
|
- Severity of diabetic neuropathy
|
1
| |
[131]
|
|
- Severity of diabetic kidney disease
|
1
| |
[132]
|
|
- Severity of diabetes related complications
|
1
| |
[133]
|
|
- Medically attended hypoglycemia
|
1
| |
[30]
|
|
Diabetes treatment related
|
7
| | |
|
- Types of anti-diabetic agents used
|
5
| |
[10, 26, 69, 134, 135]
|
|
- Dose of anti-diabetic agents
|
1
| |
[136]
|
|
- Adherence to anti-diabetic agents
|
1
| |
[31]
|
|
Other laboratory parameters
|
5
| | |
|
- Presence / levels of islet cells auto-immune antibodies levels
|
4
| |
[66, 103, 137, 138]
|
|
- Glucose-dependent insulinotropic polypepide (GIP) and glucagon like peptide-1 (GLP-1)
|
1
| |
[70]
|
|
Age at T2DM diagnosis
|
5
| |
[60, 78, 93, 103, 139]
|
|
Diabetes related risk factors
|
5
| | |
|
- Number of risk factors
|
3
|
Clinical risk groups
|
[52, 140, 141]
|
|
- Total metabolic score
|
2
| |
[61, 142]
|
|
Fasting plasma glucose
|
3
| | |
|
- Variability of fasting plasma glucose levels
|
3
| |
[55, 73, 143]
|
|
- Mean fasting plasma glucose levels
|
2
| |
[73, 143]
|
|
Duration of T2DM
|
4
| |
[103, 120, 144, 145]
|
|
Subtypes of T2DM
|
1
|
Ketosis prone T2DM or previously diagnosed T2DM with diabetic ketoacidosis [146]
|
[146]
|
|
Status of T2DM at cancer diagnosis
|
1
|
Insulin resistant /insulin sensitive [24]
|
[24]
|
|
Characteristics of T2DM
|
1
|
Ketosis
|
[134]
|
|
Severity of diabetes distress
|
1
|
17-item Diabetes Distress Scale scores [147]
|
[147]
|
|
Presence of metabolic disorder
|
1
| |
[10]
|
|
Reasons for not participating in diabetes related progam
|
1
| |
[148]
|
|
Non-diabetes medical related factors
|
18
| | |
|
Chronic kidney disease
|
6
| | |
|
- Severity of chronic kidney disease
|
4
| |
[26, 65, 68, 132]
|
|
- Presence of chronic kidney disease
|
2
| |
[10, 56]
|
|
Hypertension related
|
5
| | |
|
- Blood pressure control, variability
|
2
| |
[149, 150]
|
|
- Presence of hypertension
|
1
| |
[102]
|
|
- Presence of resistance hypertension
|
1
| |
[71]
|
|
- Number of anti-hypertensive agents
|
1
| |
[71]
|
|
Cardiovascular related
|
3
| | |
|
- Number of cardiovascular risk factors
|
1
| |
[50]
|
|
- Presence of atherosclerosis
|
1
| |
[51]
|
|
- Echocardiographic variables
|
1
| |
[102]
|
|
Physical function status related
|
2
| | |
|
- Physical functional status
|
1
| |
[151]
|
|
- Frailty
|
1
| |
[152]
|
|
Laboratory related parameters
|
2
| | |
|
- Blood biochemistries / full blood count
|
1
| |
[26]
|
|
- Low-density lipoprotein (LDL) levels
|
1
| |
[63]
|
|
Comorbidities of patients (overall)
|
1
| |
[128]
|
|
Overall medication usage
|
1
| |
[26]
|
|
Severity of pain
|
1
| |
[131]
|
|
Microaneurysm turnover and for the central retinal thickness
|
1
| |
[153]
|
|
Psychiatric or psychological related factors
|
16
| | |
|
Depression or anxiety related
|
9
| | |
|
- Presence and severity of depression and anxiety symptoms
|
3
| |
[42, 154, 155]
|
|
- Severity of depression
|
3
| |
[21, 35, 42]
|
|
- Presence of depression
|
2
| |
[27, 156]
|
|
- Patterns of depression
|
1
|
Persistant depressive symptoms, new depressive symptoms, remitted depressive symptoms, no or few depressive symptoms [29]
|
[29]
|
|
- Severity of anxiety symptoms
|
1
| |
[46]
|
|
Other psychiatric disorders / symptoms related factors
|
5
| | |
|
- Presence of sleep disturbance, fatigue
|
2
| |
[42, 131]
|
|
- Number of psychiatric conditions
|
1
| |
[22]
|
|
- Severity of psychiatric symptoms
|
1
|
Brief Psychiatric Rating Scale score
|
[35]
|
|
- Cognitive status
|
1
| |
[62]
|
|
Health related quality of life
|
3
| |
[118, 131, 157]
|
|
Patient perceptions related factors
|
2
| | |
|
- Illness perception
|
1
| |
[158]
|
|
- Perceived self-efficacy
|
1
| |
[35]
|
|
- Perceived social support
|
1
| |
[35]
|
|
Personality traits differences
|
1
| |
[159]
|
|
Healthcare systems related
|
6
| | |
|
Type of healthcare utilization
|
2
| |
[160, 161]
|
|
Type or specialty of care provider
|
2
| |
[64, 77]
|
|
Hospital admission
|
1
| |
[53]
|
|
Frequency of emergency department presentation
|
1
| |
[162]
|